This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Chinese Academy of Medical Sciences. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: The Innovations of Ming Fu
Introduction
Ming Fu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of medical science, particularly in vaccine development. His innovative work has led to the creation of a unique recombinant chemokine-antigen vaccine.
Latest Patents
Ming Fu holds 1 patent for his invention titled "Recombinant chemokine-antigen vaccine." This patent involves a recombinant gene sequence that comprises the human SLC gene, an antigen gene, and an IgG1-Fc fragment gene. The SLC gene is linked upstream to the antigen gene, while the IgG1-Fc fragment is linked downstream to the antigen gene. This invention also relates to the application of the recombinant gene sequence in the preparation of gene vaccines.
Career Highlights
Ming Fu is affiliated with the Chinese Academy of Medical Sciences, where he conducts his research and development work. His role at this esteemed institution allows him to collaborate with other experts in the field and contribute to groundbreaking medical advancements.
Collaborations
Ming Fu has worked alongside notable colleagues such as Shuren Zhang and Xueyan Zhang. Their combined expertise enhances the research efforts at the Chinese Academy of Medical Sciences.
Conclusion
Ming Fu's innovative contributions to vaccine development exemplify the importance of research in advancing medical science. His work continues to pave the way for future breakthroughs in gene therapy and immunology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile